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Vascular endothelium provides a selective barrier between the blood and tissues, participates 
in wound healing and angiogenesis, and regulates tissue recruitment of inflammatory cells. 
nuclear factor (nF)-κB transcription factors are pivotal regulators of survival and inflammation, 
and have been suggested as potential therapeutic targets in cancer and inflammatory diseases. 
Here we show that mice lacking IKKβ, the primary kinase mediating nF-κB activation, are 
smaller than littermates and born at less than the expected mendelian frequency in association 
with hypotrophic and hypovascular placentae. IKKβ-deleted endothelium manifests increased 
vascular permeability and reduced migration. surprisingly, we find that these defects result 
from loss of kinase-independent effects of IKKβ on activation of the serine-threonine kinase, 
Akt.  Together,  these  data  demonstrate  essential  roles  for  IKKβ  in  regulating  endothelial 
permeability  and  migration,  as  well  as  an  unanticipated  connection  between  IKKβ  and   
Akt signalling. 
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N
uclear factor (NF)-κB transcription factors (p65 or RelA, 
p50, p52, c-Rel, and RelB) generally exist as homo- or hetero-
dimers in the cytosol bound to one of three inhibitory, IκB, 
subunits (reviewed in ref. 1). In response to a wide variety of stimuli, 
NF-κB is classically activated through serine phosphorylation and 
degradation of IκB via the ubiquitin pathway, followed by transloca-
tion of NF-κB to the nucleus where it activates transcription. Serine 
phosphorylation of IκB is mediated by a large multi-unit complex 
containing two catalytic subunits (I kappa B kinase (IKK)α and 
IKKβ)2,3, as well as the regulatory subunit IKKγ or NEMO4. IKKα 
has an important role in skin development independent of its kinase 
activity5 as well as a specialized role in the alternative pathway of 
NF-κB activation that induces specific genes in B cells via NF-κB2   
and  RelB6.  IKKβ  appears  to  be  the  primary  kinase  mediating   
phosphorylation of IκB in most cell types and germline deletion of 
IKKβ results in embryonic lethality due to massive liver apoptosis7.
In vascular endothelium, NF-κB activation is seen in a wide   
variety  of  diseases  ranging  from  atherosclerosis8  to  cancer1.  In 
addition to a role in endothelial inflammation, previous work has   
suggested a role for NF-κB in other essential endothelial functions. 
Pharmacological inhibition of NF-κB decreases vascular perme-
ability9,  although  a  recent  report,  using  Tie2-driven  transgenic 
overexpression  of  a  superinhibitory  IκB-α  (sIκB),  demonstrated 
increased  vascular  permeability  after  mustard  oil  stimulation  as   
well as alterations in endothelial tight junctions10. Tie2-sIκB mice 
were  born  at  the  expected  frequency  and  developed  normally   
despite endothelial NF-κB inhibition10. A role in endothelial migra-
tion  has  not  been  reported,  although  IKKβ  deletion  promotes 
migration of embryonic fibroblasts11.
To better delineate the role of IKKβ in mammalian endothelium 
in vivo, we used conditional inactivation to generate endothelial-
specific  IKKβ-deleted  mice.  These  studies  show  essential  roles 
for IKKβ in the developing placental and adult somatic vascula-
ture, including regulation of endothelial apoptosis and migration,   
vascular permeability, and vasculogenesis. Surprisingly, although 
some of these effects (such as apoptosis) result from loss of IKKβ-
kinase-dependent  activation  of  NF-κB,  others  (such  as  perme-
ability  and  migration)  reflect  loss  of  kinase-independent  IKKβ 
modulation, the serine/threonine kinase, Akt. Together, these data 
demonstrate distinct kinase-dependent and -independent roles for 
IKKβ in regulating endothelial function, as well as an unanticipated   
connection between IKKβ and Akt signalling.
Results
Generation of endothelial-specific knockout mice.  To  produce 
mice with endothelial deletion of IKKβ (IKKβ∆EC), we bred Tie2-
Cre transgenic mice with IKKβflox/flox mice12 on an atherosclerosis-
prone  ApoE-null  genetic  background.  Interestingly,  Tie2-Cre + -
IKKβflox/flox-ApoE − / −   mice  were  born  at  lower  than  the  expected 
Mendelian frequency (7/48 versus 24/48 expected, P < 0.0001 by 
chi-square  analysis)  raising  the  possibility  of  prenatal  mortality 
and were ~25% smaller than Cre-negative littermates at 8 and 32 
weeks (Fig. 1a, P < 0.005 in repeated two-way ANOVA) in contrast 
to previously published results with Tie2-sIκB mice10. Collection of 
embryos after timed pregnancies revealed that 4/14 (29%) of the 
Tie2-Cre + -IKKβflox/flox embryos on either an ApoE − / −  or ApoE + / −  
were dead at E14–16 without evident gross malformation of major 
organs or vascular structures (Fig. 1b) compared with no fetal loss of 
the Tie2-Cre-negative IKKβflox/flox embryos. Interestingly, placentae 
from embryos with endothelial IKKβ deletion were hypomorphic 
with fewer blood vessels (Fig. 1c,d).
Intact vascular endothelium with altered function. Intact vascu-
lar endothelium without detectable endothelial IKKβ expression   
in  IKKβ∆EC  mice  was  demonstrated  in  confocal  immunohisto-
chemistry (Fig. 1e) and immunoperoxidase staining (Supplementary   
Fig. S1a) of mice after birth. Electron microscopy confirmed the 
presence of normal-appearing vascular endothelium, and, in con-
trast to results with transgenic overexpression of sIκB10, normal-
appearing endothelial tight junctions (Supplementary Fig. S1b–e). 
To  examine  the  structure  and  function  of  IKKβ∆EC  microvessels   
in vivo, we utilized in vivo microscopy of ear vessels after intravenous 
injection of Evans blue dye, which binds serum albumen (Fig. 2a; 
Supplementary Movie 1). Whereas vessel number and branching 
pattern appeared generally normal, dye rapidly extravasated in the 
endothelial IKKβ-knockout mice, indicating an increase in baseline 
vascular permeability even more severe than that seen in Tie2-sIκB 
mice10, as it occurred in the absence of stimulation and contrary   
to with the reduced permeability reported with pharmacological 
NF-κB inhibition9.
Another  important  function  of  vascular  endothelium  is  cel-
lular migration, which has a role in wound healing and angiogen-
esis. We measured the ability of IKKβ-deficient endothelial cells to 
migrate in response to the endothelial-specific stimulus, vascular 
endothelial growth factor (VEGF), in vitro. Endothelial cells from 
IKKβflox/flox mice were infected with a Cre-expressing adenovirus, 
which effectively mediated deletion of IKKβ and inhibited NF-κB 
activation without affecting IKK-α or -γ (Supplementary Fig. S2). 
Surprisingly, although IKKβ deletion enhanced fibroblast migra-
tion11, Cre-mediated deletion of IKKβ in endothelial cells cultured 
from  IKKβflox/flox  mice  reduced  chemotactic  migration  to  VEGF 
(Fig. 2b) and migration in a scratch wound-healing assay (Fig. 2c), 
suggesting  a  cell-specific  role  of  IKKβ  in  regulating  cell  migra-
tion. Deletion of endothelial IKKβ ex vivo also recapitulated the 
increased permeability observed in vivo (Fig. 2d). Co-infection of 
endothelial  cells  with  a  recombinant  adenovirus  encoding  wild-
type IKKβ, but not a reporter construct, largely restored endothelial 
migration and reduced permeability to normal (Fig. 2b–d) demon-
strating the specificity of this effect. Surprisingly, however, a kinase- 
inactive  mutant  of  IKKβ  (KD-IKKβ),  which  we  had  previously 
shown inhibits endothelial NF-κB activation13, also rescued these 
phenotypes with equal efficacy, suggesting they were not due to loss 
of kinase activity in the IKKβ null cells. Kinase assays confirmed that 
the wild-type IKKβ construct increased basal IKKβ kinase activity, 
which was further increased by cytokine stimulation (Supplemen-
tary Fig. S3). In contrast, the KD-IKKβ construct did not manifest 
IKKβ kinase activity at baseline or in response to IL-1 stimulation 
(Supplementary Fig. S3).
Because  NF-κB  modulates  cell  survival  through  a  variety  of   
anti-apoptotic  mechanisms1,  we  examined  the  effects  of  IKKβ  
deletion on apoptosis in endothelial cells. IKKβ deletion did not 
affect apoptosis in endothelial cells in the presence of serum but 
did result in a significant increase in apoptotic endothelial cells 
after serum deprivation (Fig. 3). Expression of wild type (WT), 
but  not  KD  IKKβ  in  IKKβ-deleted  endothelial  cells,  mitigated 
serum  starvation-induced  apoptosis  in  endothelial  cells  (Fig. 3). 
This result suggests that IKKβ has both kinase-independent and   
-dependent effects on important phenotypes of endothelial cells, 
and reinforces the specificity of results above for migration and   
permeability.
Altered Akt signalling. The abnormal growth and development as 
well as the severe vascular leakage seen in IKKβ∆EC contrasted with 
results reported with endothelial NF-κB inhibition in Tie2-sIκB 
transgenics10, despite use of the same promoter. These differences 
in  combination  with  kinase-independent  rescue  in  vitro  raised 
the possibility that IKKβ modulates baseline endothelial function 
through NF-κB-independent signalling pathways. Indeed, features 
of the IKKβ∆EC mice were reminiscent of those seen in Akt1 null 
mice,  including  increased  vascular  permeability14  and  decreased 
endothelial  migration  ex  vivo14,15,  as  well  as  prenatal  mortality, 
hypotrophic and hypovascular placentae, and small size (thought in ARTICLE     
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Akt1-null mice to reflect reduced Akt1-eNOS signalling in placen-
tal vascular endothelium16). These similarities and previous reports 
that IKK isoforms (including IKKβ)17,18 could physically interact 
with Akt prompted us to examine Akt in IKKβ∆EC mice. Interest-
ingly, phospho-Akt was markedly reduced in vascular endothelium 
from IKKβ∆EC mice (Fig. 4a). Similarly, ex vivo deletion of IKKβ 
in endothelial cells resulted in reduced phosphorylation of Akt in 
response to insulin-like growth factor (IGF)-I (Fig. 4b). A similar 
blunted response to insulin was seen in IKKβ-deleted endothelial 
cells in vitro (Supplementary Fig. S4). Phosphorylation of GSK3β 
in response to insulin was also blunted in IKKβ-deleted endothe-
lial cells, consistent with inhibition of Akt downstream signalling 
(Supplementary Fig. S5). Conversely, overexpression of either WT 
or kinase-inactive IKKβ in vitro was sufficient to increase Akt phos-
phorylation in endothelial cells (Fig. 4c), consistent with a kinase-
independent  effect  of  IKKβ  on  Akt  signalling.  Previous  reports   
suggested that Akt and IKKβ physically interact in other cell types18. 
However, we did not find consistent evidence of robust IKKβ-Akt 
interaction despite multiple immunoprecipitation, GST-pull down 
and yeast interaction assays.
Disrupted Akt trafficking. In response to growth factor stimula-
tion,  increased  phosphatidylinositol  (3,4,5)-trisphosphate  (PIP3) 
binds  the  pleckstrin  homology  domain  of  Akt  and  prompts  its 
translocation to the cell membrane, where it is localized in caveolar   
lipid  rafts  and  phosphorylated,  and  subsequently  moves  to  the 
nucleus19. Trafficking to lipid rafts has an important role in Akt 
activation20, and nuclear translocation enhances its anti-apoptotic 
effects21. IKKβ has also been reported to localize to lipid rafts22. To 
examine which step in the activation of Akt is affected by IKKβ dele-
tion, we examined intracellular Akt trafficking after stimulation with 
IGF-I in murine endothelial cells in vitro. As previously described19, 
IGF-I  stimulation  of  control  cells  induced  early  localization  of 
Akt to the membrane (evident at 5 min) followed by movement   
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Figure 1 | Phenotype of endothelial-specific IKKb knockout mice. (a) Photograph of littermate wild type (‘control’) and IKKβ∆EC (‘∆IKKβ’) mice and body 
weight ± s.d. shown from mice of each genotype at the indicated age (n = 3/each group, *P < 0.005 in repeated two-way AnoVA). (b) H&E staining  
of embryos at E14. scale bars: 1 mm. (c) staining of placentae by H&E and immunohistochemistry for von Willebrand Factor at E14. scale bars: 10 µm.  
(d) Placenta weight from mice of each genotype (n = 6 in IKKβ∆EC and n = 3 in control mice, *P < 0.05 in two-sided student’s t-test. Error bars: ± s.d.).  
(e) Confocal microscopy images of vascular endothelium in IKKβ∆EC and control mice immunostained with antibody for CD146 and IKKβ. scale bars: 100 µm.ARTICLE
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to the nucleus (at 15 min) evident by confocal immunohistochem-
istry (Supplementary Fig. S6a). Subcellular localization of phospho-
rylated Akt followed a similar pattern (Supplementary Fig. S6b). 
In contrast, in endothelial cells in which IKKβ had been deleted, 
IGF-I-induced movement of both total and phospho-Akt to the cell   
membrane at 5 min and to the nucleus at 15 min were markedly 
inhibited (Supplementary Fig. S6a and b). Separation of membrane   
compartments on a sucrose gradient further documented that IKKβ 
deletion reduced Akt in membrane lipid raft fractions after IGF-I 
stimulation  (Fig.  4d).  Similarly,  subsequent  translocation  of  Akt 
to the nucleus after IGF-I treatment was inhibited by IKKβ dele-
tion (Supplementary Fig. S6c). Importantly, endothelial caveolae 
are present in IKKβ∆EC mice and appear normal by electron micro-
scopy (Supplementary Fig. S1b–e), suggesting the observed changes 
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Figure 2 | Permeability and migration in IKKb-manipulated endothelial cells in vivo and in vitro. (a) In vivo microscopy images of ear microvessels after 
injection of Evans blue dye. Representative image at 10 min (top) and cumulative data ± s.e. from three independent experiments (bottom) are shown 
(*P < 0.005 in repeated two-way AnoVA). scale bars: 100 µm. see also supplementary movie 1 online. (b) In vitro migration to VEGF of endothelial cells 
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bars: VEGF ( + ). *P < 0.05 in two-sided student’s t-test. (c) Wound-healing assay. migration area was accumulated from six separated observation fields. 
Representative experiment is shown from three independent experiments total. *P < 0.005 in two-sided student’s t-test. **P < 0.05 in two-sided student’s 
t-test. Error bars:  ± s.d. (d) In vitro permeability of endothelial cells in which IKKβ is deleted or WT/KD-IKKβ is expressed. Cumulative data ± s.e. from three 
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in  trafficking  are  not  due  to  disruption  of  caveolae.  Expression 
of either WT- or KD-IKKβ restored Akt trafficking to lipid rafts 
(Fig. 4e), consistent with the functional rescue of permeability and 
migration mediated by these constructs. Taken together, these data 
suggest that IKKβ deletion impairs Akt trafficking and subsequent 
activation and that the ability of IKKβ to enhance Akt localization 
to lipid rafts does not require IKK kinase activity.
Akt rescues altered migration and permeability. We tested the 
functional relevance of IKKβ‘s modulation of Akt activation in vitro. 
Of note, Chen et al.14 previously demonstrated that permeability 
in Akt1-deficient endothelial cells is increased in a similar in vitro 
assay. As noted above, Cre-mediated deletion of IKKβ increased 
endothelial permeability and expression of either WT or KD IKKβ, 
which both restore Akt trafficking (Fig. 4e) and increase Akt phos-
phorylation (Fig. 4c), reduced endothelial permeability (Fig. 2d). 
Expression of activated Akt (myr-Akt) also restored permeability to 
normal in IKKβ-deleted endothelial cells (Fig. 4f). Similarly, expres-
sion of activated Akt (as well as either WT or KD IKKβ, Fig. 2b,c) 
restored the ability of IKKβ-deleted endothelial cells to migrate in 
response to VEGF (Fig. 4g) and in a scratch wound-healing assay 
(Fig.  2c)  in  vitro.  Together,  these  data  suggest  that  deletion  of   
IKKβ alters endothelial phenotype at least in part through kinase-
independent regulation of Akt activation.
Altered PTEN activity. In the absence of evidence supporting a 
robust physical interaction between IKKβ and Akt, we examined 
the PTEN phosphatase, which cleaves PIP3, removing the primary   
stimulus  for  Akt  translocation.  Inhibitory  phosphorylation  of 
PTEN was significantly decreased by IKKβ deletion in endothelial 
cells, and conversely, overexpression of KD- or WT-IKKβ increased 
PTEN  phosphorylation  (Fig.  5a–c).  These  changes  would  be 
expected to increase PTEN phosphatase activity (and decrease Akt 
translocation/phosphorylation) after IKKβ deletion, and decrease 
PTEN phosphatase activity in a kinase-independent manner with 
overexpression. Direct measurement of PTEN phosphatase activity 
(Fig. 5d) confirmed that this was indeed the case. Taken together, 
these  data  implicate  PTEN  as  a  mediator  of  cross-talk  between 
IKKβ and Akt, most likely through effects on the well-described 
pathway of PIP3-induced Akt membrane localization.
Impaired ischemia-induced vasculogenesis. The defect in VEGF-
induced endothelial migration seen in  vitro after IKKβ deletion 
raised the possibility that endothelial IKKβ would important in vas-
culogenesis or the formation of new blood vessels in adults. Given 
the small number of homozygous IKKβ∆EC mice available for study, 
we addressed this question in heterozygous IKKβ∆EC mice. After 
ligation of the common femoral artery, return of collateral flow was 
markedly impaired in heterozygous IKKβ∆EC mice (Fig. 6). These 
data are consistent with our in vitro observations and underscore 
the potential pathophysiological importance of endothelial IKKβ in 
vasculogenesis due to ischemia or potentially other stimuli.
Discussion
To better delineate the role of IKKβ in mammalian endothelium, 
we used conditional inactivation to generate mice with endothelial-
specific inaction of IKKβ (IKKβ∆EC). Gestational loss of IKKβ∆EC 
embryos and stunted growth probably resulted from hypomorphic 
placentae. Late stage embryos and surviving adults manifested an 
intact somatic vasculature with surprisingly normal morphology. 
Loss  of  IKKβ  blocked  endothelial  NF-κB  activation.  Whereas 
endothelial apoptosis was not increased at baseline, IKKβ-deleted 
endothelial  cells  were  more  susceptible  to  serum  deprivation-
induced apoptosis in vitro and apoptosis was mitigated by expres-
sion  of  wild-type  but  not  kinase-inactive  IKKβ.  Adult  animals 
lacking endothelial IKKβ manifest increased vascular permeabil-
ity and impaired vasculogenesis in response to ischemia. In vitro, 
IKKβ-deleted endothelial cells also demonstrated increased per-
meability and reduced migration. Surprisingly, these defects were 
rescued equally well by wild-type and kinase-inactive IKKβ and 
appear  related  to  kinase-independent  activation  by  IKKβ  of  the 
serine/threonine kinase, Akt. Taken together, these data establish 
an important physiological role for IKKβ in regulating a variety 
of  endothelial  functions  in  mammals,  and  show  unanticipated   
kinase-independent effects of IKKβ mediating cross-talk with Akt 
signalling.
The  increased  vascular  permeability  seen  in  vivo  in  IKKβ∆EC 
mice, is more severe than that seen with either isolated Akt1 dele-
tion14 or transgenic endothelial NF-κB inhibition10, probably reflect-
ing the combined effects of endothelial inhibition of both Akt and 
IKKβ-NF-κB signalling. This inference is reinforced by the complex 
relationship of Akt signalling to endothelial permeability. Although 
Chen et al.10 found increased permeability in Akt1 − / −  endothelium 
both in vivo and in an in vitro model similar to the one used here, 
Ackah et al.15 found reduced vascular permeability in Akt1 − / −  mice 
in response to VEGF. These differences may reflect technical aspects 
of the assays used and/or the time-points examined. In addition, the 
IKKβ∆EC mice studied here differ from the Akt1 − / −  mice not only in 
the primary and concomitant loss of endothelial IKKβ signalling 
but also in that Akt signalling is preserved in non-endothelial cells, 
which may be an important source of a variety of factors affecting 
vascular permeability including VEGF and angiopoietins.
Our data document cross-talk between two central signalling 
molecules, IKKβ and Akt, in endothelial cells in vitro and in vivo 
that  appears  mediated  via  the  phosphatase,  PTEN.  Our  results   
differ from previous reports in important respects. First, although 
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we  do  find  evidence  of  a  signalling  connection  similar  to  that 
described previously17,18,23, here we find that Akt lies downstream 
of IKKβ (rather than the reverse), and the two molecules work 
together to exert important effects on baseline endothelial function. 
In addition, although it is difficult to completely exclude physical 
interaction as a contributor to these effects, our data suggest that 
PTEN  has  an  important  role  as  an  intermediary.  It  is  not  clear 
whether these kinase-independent effects of IKKβ work via the IKK 
signalling complex. The observation that overexpression of IKKβ 
at levels nonstoichiometric to other components of the IKK com-
plex increases Akt activation, raises the possibility that IKKβ acts 
independent of the complex in this context. In addition, we note 
that IKKα knockout mice24 do not phenocopy any of the features 
we observed in IKKβ endothelial knockout mice, further support-
ing the hypothesis that IKKβ’s role in this context does not require 
IKKα. However, testing these hypotheses awaits delineation of the 
precise  molecular  mechanism  by  which  IKKβ  modulates  PTEN 
activity.
In contrast to our results, several studies in other tissues have 
reported  that  IKKβ  activation  can  inhibit  insulin  signalling  in   
general and Akt in particular20,25,26. These differences may reflect tissue   
specific roles of IKKβ, similar to the skin-specific effects revealed   
by IKKα deletion5. However, even in other tissues, IKKβ-induced 
inhibition  of  Akt  signalling  was  most  pronounced  in  chronic 
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inflammatory states or tissues with significant basal NF-κB acti-
vation20,25,26. The findings reported here occur in unactivated endo-
thelial cells at baseline. As noted above, we also provide evidence 
of  kinase-dependent  effects  of  IKKβ  on  important  endothelial 
phenotypes  (for  example,  apoptosis),  although  not  under  basal 
conditions. Thus, it is quite possible that the relative importance of 
kinase-dependent and -independent IKKβ effects would shift, even 
in endothelial cells, in an inflammatory milieu. Nevertheless, these 
results broaden our understanding of the complex interactions of 
the IKK signalosome and demonstrate that IKKβ has important 
kinase-  and  NF-κB-independent  effects,  similar  conceptually  to 
those shown previously for IKKα5, in addition to its well-docu-
mented kinase-dependent effects.
Most importantly, these data establish an essential role for IKKβ 
in fundamental endothelial functions including permeability and 
migration,  and  demonstrate  the  pathophysiological  relevance  of 
these effects in a model of ischemia-induced neovascularization. 
These findings and the observed interaction with Akt signalling 
may complicate efforts to target IKKβ in some diseases such as 
atherosclerosis but could be advantageous in other settings. For 
example, recent work suggests sustained endothelial Akt activation 
is  necessary  for  maintenance  of  abnormal  tumour  vasculature27. 
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As IKKβ is also a potential target for cancer therapy1, strategies 
aimed  at  decreasing  IKKβ  expression  could  provide  additional   
benefit through secondary inhibition of endothelial Akt signalling 
and potentially through inhibition of angiogenesis. Understanding 
the role of IKKβ in vascular endothelium and the associated signal-
ling cascades could help guide therapeutic strategies for a variety of 
conditions marked by endothelial activation and dysfunction.
Methods
Antibodies and reagents. Antibodies used include monoclonal anti-IKKβ 
(Upstate), polyclonal anti-IKKβ (H-470, Santa Cruz Biotechnology), anti-CD146 
(Chemicon), anti-total and phospho-(Ser473)Akt, total and phospho-(Ser380/
Thr382/383)PTEN, phospho-GSK3α/β (Cell Signaling). Catch & Release Immuno-
precipitation kit (Upstate), ApopTag Red Apoptosis detection kit (Chemicon), 
NE-PER Nuclear and Cytoplasmic Extraction Reagents Kit (Pierce) and Cell 
Lysis Buffer (Cell Signaling ) were used in accordance with the manufacturers’ 
instructions. Adenoviral vectors encoding WT IKKβ, kinase-defective (KD) IKKβ, 
myrAkt, EGFP, Cre and LacZ have been described previously in detail13,28.
Animal studies. All animal studies were performed after institutional approval and 
in compliance with applicable guidelines for animal experimentation. IKKβflox/flox 
mice were mated with ApoE − / −  (Jackson Immunoresearch Laboratories) to  
generate IKKβflox/flox ApoE − / −  mice which were mated with male Tie2-Cre mice 
to generate ultimately Tie2-Cre + -IKKβflox/flox-ApoE − / −  or Tie2-Cre + -IKKβflox/flox-
ApoE + / −  mice. As the phenotype appeared identical on the ApoE − / −  or  + / −  back-
ground, data from these mice was combined in some studies.
Immunohistochemistry. Slides were incubated in 80% acetone (2 min, 4 °C) 
and incubated in 3% hydrogen peroxide for 10 min. After incubation for 60 min, 
in blocking solution (5% goat serum, 5% donkey serum in tris buffered saline 
(TBS)), slides were incubated with diluted antibody for pAkt (1:50), polyclonal 
IKKβ (1:100) and CD146 (1:100) overnight at 4 °C. Diluted FITC-conjugated goat 
anti-mouse and rhodamine-conjugated donkey anti-rabbit secondary antibodies 
(Jackson, 1:100) were applied to the slides for 60 min.
Immunoperoxidase staining. Slides were incubated with Avidin Block (Vector 
Laboratories SP-2001, Avidin-Biotin blocking kit) for 15 min before apply-
ing Biotin Block for fifteen minutes. Diluted rabbit anti-Von Willibrand Factor 
(Chemicon, 1:200) was applied to each slide (4 °C, overnight). Diluted biotinylated 
donkey anti-rabbit secondary antibody (Jackson, 1:200) was applied for 60 min at 
room temperature. ABC reagent (Vector ) was applied to slides for 30 min at room 
temperature. DAB solution (diluted 1:10 in TBS, pH 7.6) added with 3% hydrogen 
peroxide (1:125) was applied to slides for approximately 1 min. Slides were then 
counterstained with hematoxylin.
In vivo permeability assay. Vessel permeability was assessed by leakage of the 
Evans blue dye from the mouse ear vasculature following intravenous injection. An 
intravenous catheter was inserted into the tail vein of anaesthetized mouse before 
placing the mouse on the stage of a video-rate scanning laser confocal microscope. 
The ear skin was gently spread onto a coverglass with a drop of 1% methocellulose. 
At the start of each experiment, 100 µl of 2% Evan’s blue dye was injected via the 
tail vein. Images were acquired from an appropriate vascular area (at about 50 µm 
under the surface of the skin) and every 30 s for at least 10 min after injection. 
Each image was acquired by averaging 30 video frames (1 s integration time) using 
an Olympus 60×, numerical aperture 1.2, water-immersion objective producing 
optical sectioning images with sub-micron resolution comprising 500×500 pixels 
in a 300 µm×300 µm field of view. Evan’s blue dye was excited by a 635 nm laser 
(Edmund Optics) and fluorescence detected through a 695 ± 27.5 nm bandpass 
filter (Omega Optical) by a photo multiplier tube (Hamamatsu). To determine 
vessel permeability, acquired images (as a function of time) were first co-registered 
and then put in ImageJ as a stack. Using the polygonal selection tool, the change 
in fluorescence intensity was recorded in 4–8 tissues areas adjacent to blood vessel 
per stack. The fold increase of each transgenic animal (n = 3) was normalized to its 
littermate control at 2 min after injection and results were pooled.
Endothelial cell culture. Lungs of IKKβflox/flox mice were harvested, minced finely 
and digested in 25 ml collagenase (Roche, 2 mg ml − 1). Cells were incubated with 
anti-PECAM-1 antibody (BD Biosciences, 1:100) and cells bound with antibody 
were isolated magnetically with mouse anti-rat kappa microbead (Miltenyi Biotec), 
washed with complete media (DMEM, 20% FCS, 0.1 mg ml − 1 heparin, 0.1 mg ml − 1 
endothelial cell mitogen (Biomedical Technologies), nonessential amino acids, 
sodium pyruvate, L-glutamine and penicillin/streptomycin at standard concentra-
tions) and cultured in fibronectin-coated, tissue-culture flasks. Nonadherent cells 
were removed after 24 h and media replaced. At confluence, endothelial cells were 
magnetically selected further using anti-ICAM-2 antibody (BD Biosciences, 1:100).
Endothelial migration assay. Endothelial cells were suspended at 5×105 cells ml − 1 
and 100 µl were added to the top chamber of a fibronectin-coated transwell  
apparatus (6.5-mm diameter, 8-µm pore size Costar, Corning Incorporated) whose 
lower chamber was filled with 600 µl DMEM containing 50 ng ml − 1 VEGF where 
indicated (Pepro Tech). Cells were incubated for 6 h at 37 °C in an atmosphere 
containing 5% CO2, and then fixed with ice-cold methanol for 20 min. Migrated 
cells were counted after staining with Hema3 Manual Staining System (Fisher 
Scientific)29.
In vitro permeability assay. Permeability assay was performed according to 
product manual (In vitro Vascular Permeability Assay from Millipore: ECM640). 
Endothelial cells monolayer forms on collagen-coated inserts which contain 1.0 µm 
symmetrical pores within a transparent polyethylene membrane. 150 µl of cell 
culture medium containing 1:40 FITC-Dextran is added on the top of the cells 
and incubated at 37 °C for three hours. The extent of permeability is determined 
by measuring the fluorescence of the plate well solution using excitation/emission 
wavelength of 485 nm/530 nm.
Wound-healing assay. Confluent endothelial monolayers in 6 cm dishes were 
scraped with sterilized 1 ml micropipette tips to create a cell-free zone. Microscopic 
images were captured at 0 and 36 h later, and the percent of the migrated area was 
quantified using Image J software (National Institutes of Health, USA).
Sucrose gradient. Endothelial cells were infected with the indicated adenoviral 
vectors, treated with 10 nM IGF-I or PBS for 15 min, and lysed in cell lysis buffer 
(Cell Signaling ) containing 1 mM phenylmethylsulfonyl fluoride (PMSF). An 
identical amount of protein from each sample was mixed with 60% sucrose in 
PBS/MBS buffer 3 ml (final volume, sucrose concentration 51.7–58.7%), and trans-
ferred to a Beckman Ultracentrifuge tube. 3 ml of 35% sucrose followed by 4 ml of 
5% sucrose were overlaid. Samples were ultracentrifuged (38,000 r.p.m.≅180,000×g 
in SW41 rotor (Beckman Coulter), 20 h) and 24 fractions were collected from the 
top of the gradient. For detection of lipid raft fractions, all fractions were dot-blot-
ted with HRP-labeled cholera toxin B (Sigma) to detect Ganglioside GM1, and raft 
fractions were immunoblotted for caveolin-1 (BD biosciences) for confirmation.
PTEN activity assay. PTEN activity assay was performed according to product 
manual (PTEN Activity Assay from Echelon: K-2300). Immunoprecipitated PTEN 
beads were washed with cell lysis buffer twice and with PTEN reaction buffer 
(10 mM Hepes, 150 mM NaCl, 10 mM DTT, ph 7.2) once, and re-suspended with 
300 µl reaction buffer. 100 µl sample was added to each well of PI(3,4,5)P3-coated 
PTEN substrate plate, and plate was incubated for 90 min at 37 °C. Each well was 
washed with 200 µl of TBS-T three times, and PI(4,5)P2 detector was added to the 
well. Plate was incubated for 1 h at room temperature, and washed with 200 µl of 
TBS-T three times. 100 µl of HRP conjugate working solution prepared by diluting 
HRP conjugate 1:40 with TBS-GT was added to each well, and plate was incubated 
for 1 h at room temperature. After washing with 200 µl of TBS-T three times, 100 µl 
of TMB (Cell Signaling ) was added to each well and plate was incubated for 30 min 
at room temperature. Reaction was stopped with 50 µl per well of stop solution (Cell 
Signaling) and absorbance was read at 450 nm. The values were compared with the 
standard curve to quantify conversion of PI(3,4,5)P3 substrate to PI(4,5)P2.
Femoral artery ligation. The epigastric and deep femoral arteries were cauterized. 
Proximal and distal sutures were placed around the femoral artery which was then 
cut between the ligatures. Immediately and one week after surgery, hindlimb blood 
flow was assessed using laser doppler imaging (LDI-2, Moor Inc). Flux, correlat-
ing to vascular limb perfusion, was quantitated using the Moor LDI-Main V51 
software, and expressed as a ratio of the flux in the ischemic limb to that in the 
unoperated, nonischemic limb.
Statistical analysis. Unless otherwise specified in the text, statistical comparisons 
were made with two-sided Student’s t-test. 
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